InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: hschlauch post# 40465

Friday, 10/20/2017 5:33:36 PM

Friday, October 20, 2017 5:33:36 PM

Post# of 48316
Even if it is priced at half that, Oncosec will make a hell of a lot of money. Orphan drug designation comes with economic incentive too. $150,000 per patient in all reality is probably too high but would be nice.